The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Advancing Light Therapy Research to Enhance Quality of Life for Parkinson's Patients This trial is important becau ...
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
With thousands of press releases published each month, it can be difficult to keep up with everything on . To help healthcare ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.
FDA aligned on single-arm Phase 3 study to support potential accelerated and full approvalOn track to dose first patient in Phase 3 trial in ...
Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
This has the capacity to connect generations in a caring, helping way, which you can’t do artificially. I have to admit, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback